ICYMI: PhRMA CEO Stephen J. Ubl spotlights lessons learned during COVID-19

This week, PhRMA sponsored The Washington Post’s event, Coronavirus: Lessons of the Pandemic, where PhRMA president and CEO Stephen J. Ubl shared crucial lessons learned from the pandemic on how to...
Read More
ICYMI: PhRMA COO Lori Reilly spotlights efforts to improve health care in 2022 and beyond

The COVID-19 pandemic has made clear how important a stable health care system is to the American people, both during times of crisis and beyond. Patients deserve sustainable, patient-centered...
Read More
A conversation with Barry Greene, CEO of Sage Therapeutics

Our industry continues working to build a more resilient, affordable and equitable health care system. As part of Mental Health Awareness Month, I recently had the opportunity to connect with PhRMA...
Read More
ICYMI: New resource catalogs biopharmaceutical industry lessons learned from COVID-19

Since the start of the pandemic, America’s biopharmaceutical companies have worked around the clock to research, develop and manufacture treatments and vaccines to fight COVID-19. We’ve made...
Read More
New Data: COVID-19 vaccine global production capacity projected to exceed 20 billion doses this year

Biopharmaceutical companies are working across the industry and around the world to meet the global demand for COVID-19 vaccines. Companies have continued to ramp up their efforts to source needed...
Read More
What you need to know about newly authorized COVID-19 antiviral treatments

In December 2021, the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for the first two oral antivirals for the treatment of certain COVID-19 patients. These...
Read More
Guest post: Joining forces to combat the COVID-19 mental health crisis

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
Guest Blog: COVID-19 vaccines are the key to keeping kids healthy

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
Protecting U.S. innovation abroad to support economic and pandemic recovery

PhRMA’s recently submitted comments to the Office of the U.S. Trade Representative (USTR)’s 2022 Special 301 Report reinforce how the United States can confirm its strong commitment to defend...
Read More
ICYMI: New report demonstrates growing global impact of antimicrobial resistance

New research published in The Lancet shows for the first time the global impact of antimicrobial resistance (AMR), which poses an increasingly serious threat to human health around the world. The...
Read More